Institutional Ownership Adaptimmune Therapeutics PLC (ADAP)
This table provides information about the institutional ownership of Adaptimmune Therapeutics PLC (ADAP). We have compiled data on the 83 institutions that hold shares in the stock, with a total of 145 Million shares, which have been reported (via 13F filing form) to have a value of $87 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Clear Harbor Asset Management, LLC
|
Jan 16, 2025 Q4 2024 |
18,525
shares
|
$11,115
0.0% of portfolio
|
Q4 2024
New holding
|
|
Baader Bank Aktiengesellschaft
Unterschleissheim, 2M |
Jan 23, 2025 Q4 2024 |
18,095
shares
|
$10,857
0.0% of portfolio
|
Q4 2024
New holding
|
|
Columbia Advisory Partners LLC
|
Jan 13, 2025 Q4 2024 |
16,420
shares
|
$9,852
0.01% of portfolio
|
Q4 2024
Reduced 47.74%
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Nov 13, 2024 Q3 2024 |
15,258
shares
|
$9,154
0.0% of portfolio
|
Q2 2024
Reduced 20.77%
|
|
Commonwealth Equity Services, LLC
|
Oct 18, 2024 Q3 2024 |
13,433
shares
|
$8,059
0.0% of portfolio
|
Q3 2024
Reduced 33.48%
|
|
Graham Capital Management, L.P.
Rowayton, CT |
Nov 14, 2024 Q3 2024 |
12,592
shares
|
$7,555
0.0% of portfolio
|
Q3 2024
New holding
|
|
Quadrant Capital Group LLC
Cincinnati, OH |
Nov 12, 2024 Q3 2024 |
12,280
shares
|
$7,368
0.0% of portfolio
|
Q3 2024
Added 281.6%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2024 Q3 2024 |
11,948
shares
|
$7,168
0.0% of portfolio
|
Q3 2024
Reduced 64.16%
|
|
X Square Capital, LLC
|
Oct 22, 2024 Q3 2024 |
11,180
shares
|
$6,708
0.0% of portfolio
|
Q3 2024
Reduced 0.11%
|
|
R Squared LTD
Central, K3 |
Jan 22, 2025 Q4 2024 |
8,770
shares
|
$5,262
0.0% of portfolio
|
Q4 2024
New holding
|
|
Parallel Advisors, LLC
|
Nov 13, 2024 Q3 2024 |
7,183
shares
|
$4,309
0.0% of portfolio
|
Q3 2024
Added 2773.2%
|
|
Signaturefd, LLC
Atlanta, GA |
Oct 21, 2024 Q3 2024 |
6,620
shares
|
$3,972
0.0% of portfolio
|
Q3 2024
New holding
|
|
Global Retirement Partners, LLC
|
Jan 31, 2025 Q4 2024 |
6,000
shares
|
$3,600
0.0% of portfolio
|
Q1 2023
New holding
|
|
Lindbrook Capital, LLC
|
Nov 01, 2024 Q3 2024 |
4,847
shares
|
$2,908
0.0% of portfolio
|
Q3 2024
Added 5.14%
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Nov 14, 2024 Q3 2024 |
4,665
shares
|
$2,799
0.0% of portfolio
|
Q3 2024
New holding
|
|
Cibc Private Wealth Group, LLC
|
Nov 13, 2024 Q3 2024 |
3,023
shares
|
$1,813
0.0% of portfolio
|
Q2 2024
Reduced 96.06%
|
|
Ifp Advisors, Inc
|
Jul 30, 2024 Q2 2024 |
3,023
shares
|
$1,813
0.0% of portfolio
|
Q2 2024
New holding
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
1,817
shares
|
$1,090
0.0% of portfolio
|
Q2 2024
Reduced 99.08%
|
|
Simplex Trading, LLC
|
Nov 08, 2024 Q3 2024 |
1,052
shares
|
$631
0.0% of portfolio
|
Q3 2024
New holding
|
|
Sandy Spring Bank
|
Oct 25, 2024 Q3 2024 |
1,050
shares
|
$630
0.0% of portfolio
|
Q3 2023
New holding
|
|
Plante Moran Financial Advisors, LLC
|
Oct 30, 2024 Q3 2024 |
925
shares
|
$555
0.0% of portfolio
|
Q3 2024
New holding
|
|
Federation Des Caisses Desjardins Du Quebec
Levis, A8 |
Nov 13, 2024 Q3 2024 |
755
shares
|
$453
0.0% of portfolio
|
Q3 2024
Reduced 3.82%
|
|
Bryn Mawr Trust CO
Bryn Mawr, PA |
Jan 28, 2025 Q4 2024 |
604
shares
|
$362
0.0% of portfolio
|
Q3 2024
New holding
|
|
Carmichael Hill & Associates, Inc.
|
Oct 29, 2024 Q3 2024 |
525
shares
|
$315
0.0% of portfolio
|
Q1 2022
Added 50.0%
|
|
High Mark Wealth Management LLC
|
Jan 31, 2025 Q4 2024 |
287
shares
|
$172
0.0% of portfolio
|
Q3 2023
Reduced 77.38%
|